Phigenix was profiled in the September 30, 2011 edition of the Atlanta Business Chronicle as part of their segment featuring "interesting new technologies developed by Georgia companies and researchers". The article stated that "Phigenix is seeking to patent a way to prevent or treat prostate cancer. The method inhibits the expression of the PAX2 gene". The article goes further to say that "Phigenix has also filed for a patent for a treatment for breast cancer. Learn more about Phigenix at http://phigenix.com".